Foodprint 1.0: Physiological Acute Responses After Consumption of Confectionary Products
FP1
Foodprint 1.0: Metabolic, Hormonal, Inflammatory and Oxidative Post-prandial Responses After Consumption of Confectionary Products
1 other identifier
interventional
13
1 country
1
Brief Summary
The composition of a food or a meal consumed plays an important role in the rate of postprandial endocrine and metabolic response, especially if high in fats, sugars and total energy content and a reduction in its entity is related to beneficial effects towards the prevention of several chronical diseases. The physiological postprandial response depends on several factors, both intrinsic, such as natural characteristic of food, and extrinsic, such as the way in which food is processed. This study aims at investigating postprandial hormonal, metabolic, oxidative stress, inflammation and endotoxaemia responses after the consumption of different commercial confectionary products made with different reformulation (ingredients and/or processing techniques).The principal scope of the study is to evaluate the impact of the reformulation of different snacks on postprandial responses. The investigators therefore designed a randomized controlled crossover trial, in which 15 healthy volunteers will consume different isocaloric confectionary products (snacks) and their related reformulation (total products number = 6) and a reference snack. Venous blood samples will be collected until 4-h after meal consumption. In order to evaluate postprandial hormonal, metabolic, oxidative stress, inflammation and endotoxaemia responses several markers will be evaluate:
- metabolic substrates: glucose; Triglycerides and NEFA;
- hormones: insulin; c-peptide; GLP-1, GIP, leptin, ghrelin, PYY;
- markers of inflammation: IL-6, IL-8, IL-10, IL-17, TNF-α, hsCRP, MCP-1;
- markers of oxidative stress and antioxidant capacity: GSH, FRAP;
- endotoxaemia: lipopolysaccharides (LPS). These results will contribute to a detailed evaluation of the effects of reformulation on physiological events after meal consumption, leading to clarify if these variations in ingredients and/or processing techniques can modify postprandial responses, making them more similar to those originated from the reference snack.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 22, 2019
CompletedFirst Submitted
Initial submission to the registry
May 31, 2019
CompletedFirst Posted
Study publicly available on registry
June 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedApril 27, 2021
April 1, 2021
4 months
May 31, 2019
April 26, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
IAUC postprandial blood glucose
Incremental area under the curve of blood glucose postprandial response (IAUC)
0 (fasting), 15, 30, 45, 60, 90, 120, 180, 240 minutes
Secondary Outcomes (11)
Postprandial response for blood glucose
0 (fasting), 15, 30, 45, 60, 90, 120, 180, 240 minutes
IAUC postprandial blood hormones (insulin, c-peptide, ghrelin, Glucagon-like peptide 1 (GLP-1), Gastric inhibitory peptide (GIP), peptide YY (PYY), leptin)
0 (fasting), 15, 30, 45, 60, 90, 120, 180, 240 minutes
Postprandial response for blood hormones (insulin, c-peptide, ghrelin, Glucagon-like peptide 1 (GLP-1), Gastric inhibitory peptide (GIP), peptide YY (PYY), leptin)
0 (fasting), 15, 30, 45, 60, 90, 120, 180, 240 minutes
IAUC postprandial blood lipids triglycerides (TAG) and non esterified fatty acid (NEFA)
0 (fasting), 30, 60, 90, 120, 180, 240 minutes
Postprandial response for blood lipids triglycerides (TAG) and non esterified fatty acid (NEFA)
0 (fasting), 30, 60, 90, 120, 180, 240 minutes
- +6 more secondary outcomes
Other Outcomes (3)
Postprandial satiety using a 100mm visual analog scale
0 (fasting), 15, 30, 60, 120, 240 minutes
Palatability
12 minutes (after consumption)
Postprandial gastrointestinal symptoms using a 100mm visual analog scale
0 (fasting), 15, 30, 60, 120, 240 minutes
Study Arms (7)
control snack
ACTIVE COMPARATORcontrol snack
control cream
EXPERIMENTALcontrol spreadable cream
cream version 1
EXPERIMENTALcontrol spreadable cream, version 1
cream version 2
EXPERIMENTALcontrol spreadable cream, version 2
cream version 3
EXPERIMENTALcontrol spreadable cream, version 3
control chocolate bar
EXPERIMENTALcontrol chocolate bar
chocolate bar version 1
EXPERIMENTALcontrol chocolate bar version 1
Interventions
commercial spreadable cocoa and hazelnut cream (200 kcal)+ 250 ml water
commercial spreadable cocoa and hazelnut cream (200 kcal), version 1+ 250 ml water
commercial spreadable cocoa and hazelnut cream (200 kcal), version 2+ 250 ml water
commercial spreadable cocoa and hazelnut cream (200 kcal), version 3+ 250 ml water
commercial chocolate bar (200 kcal), version 1+ 250 ml water
Eligibility Criteria
You may qualify if:
- \- Healthy male and female adult subjects
You may not qualify if:
- BMI \> 30 kg/m2
- Metabolic disorders (diabetes, hypertension, dyslipidemia, glucidic intolerance)
- Chronic drug therapies for any pathologies (including psychiatric diseases)
- Dietary supplements affecting metabolism of glucose and lipid
- Celiac disease
- Pregnancy or lactation
- Lactose intolerance
- Food allergies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Parma
Parma, 43125, Italy
Related Publications (5)
Emerson SR, Kurti SP, Harms CA, Haub MD, Melgarejo T, Logan C, Rosenkranz SK. Magnitude and Timing of the Postprandial Inflammatory Response to a High-Fat Meal in Healthy Adults: A Systematic Review. Adv Nutr. 2017 Mar 15;8(2):213-225. doi: 10.3945/an.116.014431. Print 2017 Mar.
PMID: 28298267BACKGROUNDErridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr. 2007 Nov;86(5):1286-92. doi: 10.1093/ajcn/86.5.1286.
PMID: 17991637BACKGROUNDHerieka M, Erridge C. High-fat meal induced postprandial inflammation. Mol Nutr Food Res. 2014 Jan;58(1):136-46. doi: 10.1002/mnfr.201300104. Epub 2013 Jul 12.
PMID: 23847095BACKGROUNDO'Keefe JH, Bell DS. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol. 2007 Sep 1;100(5):899-904. doi: 10.1016/j.amjcard.2007.03.107. Epub 2007 Jun 26.
PMID: 17719342BACKGROUNDTreib J, Haass A, Kiessig ST, Woessner R, Grauer MT, Schimrigk K. Tick-borne encephalitis diagnosis in patients with inflammatory changes in the cerebrospinal fluid in a region with very low prevalence. Infection. 1996 Sep-Oct;24(5):400-2. doi: 10.1007/BF01716095.
PMID: 8923057BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Nutrition at Department of Veterinary Science, University of Parma
Study Record Dates
First Submitted
May 31, 2019
First Posted
June 4, 2019
Study Start
March 22, 2019
Primary Completion
July 31, 2019
Study Completion
December 31, 2020
Last Updated
April 27, 2021
Record last verified: 2021-04